1 Bleeding‐related mortality |
1 |
37 |
Risk Ratio (M‐H, Random, 95% CI) |
0.43 [0.09, 2.04] |
1.1 Randomised trial |
1 |
37 |
Risk Ratio (M‐H, Random, 95% CI) |
0.43 [0.09, 2.04] |
2 Failure of intervention |
1 |
17 |
Risk Ratio (M‐H, Random, 95% CI) |
0.36 [0.09, 1.35] |
2.1 Randomised trial |
1 |
17 |
Risk Ratio (M‐H, Random, 95% CI) |
0.36 [0.09, 1.35] |
3 Re‐bleeding |
1 |
37 |
Risk Ratio (M‐H, Random, 95% CI) |
0.85 [0.30, 2.45] |
3.1 Randomised trial |
1 |
37 |
Risk Ratio (M‐H, Random, 95% CI) |
0.85 [0.30, 2.45] |
4 Adverse effects (fever) |
1 |
37 |
Risk Ratio (M‐H, Random, 95% CI) |
0.43 [0.22, 0.80] |
4.1 Randomised trial |
1 |
37 |
Risk Ratio (M‐H, Random, 95% CI) |
0.43 [0.22, 0.80] |
5 Adverse effects (ulceration) |
1 |
37 |
Risk Ratio (M‐H, Random, 95% CI) |
0.79 [0.53, 1.17] |
6 Control of bleeding |
1 |
37 |
Risk Ratio (M‐H, Random, 95% CI) |
1.79 [1.13, 2.84] |